Dr. R. Michael Tuttle on New Horizons for Radioactive Iodine Treatment
R. Michael Tuttle, MD, professor of Medicine, Memorial Sloan Kettering Cancer Center, talks about the new horizons for radioactive iodine treatment in thyroid cancer.
Augmenting Pre-Operative Risk of Recurrence Stratification in DTC
R. Michael Tuttle, MD, discusses a study that looked at augmenting pre-operative risk of recurrence stratification in differentiated thyroid carcinoma.